Director, Medical Affairs Oncology, Japan
Regeneron Pharmaceuticals
About this role
The Director of Medical Affairs Oncology in Japan at Regeneron serves as the local medical expert responsible for advancing oncology assets and the clinical pipeline. The role represents Regeneron to external stakeholders and collaborates across internal teams to support medical strategy, clinical development, and improved patient care.
Skills
Qualifications
About Regeneron Pharmaceuticals
regeneron.comDiscover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Recent company news
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Capital Research Global Investors Raises Stake in Regeneron Pharmaceuticals, Inc. $REGN
7 hours ago
About Regeneron Pharmaceuticals
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Salary
$156k – $211k
per year
More jobs at Regeneron Pharmaceuticals
Similar Jobs
Associate Medical Director, Hematology, Japan
BeOne Medicines
Scientific Director, Global Oncology Pipeline, Medical Affairs
AbbVie
Medical Affairs Manager - Oncology
MSD
Oncology Medical Lead, Medical Affairs, Europe
GSK plc
Field Medical Director, GBM
ImmunityBio
Medical Affairs Senior Director, Oncology – Colorectal Cancer
Takeda Pharmaceutical Company